UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 77 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2013. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q3 2018$136,670,000
-2.3%
80,3940.0%0.00%
Q2 2018$139,886,000
-4.9%
80,3940.0%0.00%
Q1 2018$147,121,000
-17.9%
80,3940.0%0.00%
Q4 2017$179,278,000
-23.1%
80,3940.0%0.00%
Q3 2017$233,142,000
-33.5%
80,394
+2.1%
0.00%
Q2 2017$350,566,000
-4.3%
78,779
+0.2%
0.00%
Q1 2017$366,444,000
+112652.0%
78,636
+47.4%
0.00%
Q4 2016$325,0000.0%53,336
-9.3%
0.00%
Q3 2016$325,000
+92.3%
58,836
+32.5%
0.00%
Q2 2016$169,000
+37.4%
44,4000.0%0.00%
Q1 2016$123,000
-56.4%
44,400
-10.7%
0.00%
Q4 2015$282,000
-91.6%
49,700
-92.2%
0.00%
-100.0%
Q3 2015$3,365,000
-36.5%
634,900
-0.6%
0.00%
-20.0%
Q2 2015$5,301,000
+80.6%
638,700
+0.5%
0.01%
+66.7%
Q1 2015$2,936,000
+52.1%
635,400
+0.4%
0.00%
+50.0%
Q4 2014$1,930,000
+11.8%
632,800
+2.1%
0.00%0.0%
Q3 2014$1,726,000
-31.6%
619,8000.0%0.00%
-33.3%
Q2 2014$2,523,000
-23.3%
619,8000.0%0.00%
-25.0%
Q1 2014$3,291,000
-5.7%
619,8000.0%0.00%0.0%
Q4 2013$3,489,000
+22.2%
619,800
-0.8%
0.00%0.0%
Q3 2013$2,855,000624,7000.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q3 2013
NameSharesValueWeighting ↓
Alpine Partners USVI, LLC 152,500$697,0002.61%
Trellus Management Company, LLC 155,800$712,0000.90%
WALL STREET ASSOCIATES 942,200$4,306,0000.40%
BAILARD, INC. 340,500$1,556,0000.30%
Baker Brothers Advisors 2,608,271$11,920,0000.17%
STONERIDGE INVESTMENT PARTNERS LLC 104,158$476,0000.10%
Cambridge Investment Research Advisors, Inc. 449,080$2,052,0000.09%
BTG Pactual Global Asset Management Ltd 33,700$154,0000.03%
HighTower Advisors, LLC 242,001$1,106,0000.03%
BHF Kleinwort Benson Group S.A. 39,000$178,0000.02%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders